SCHEDULE 13G 0001288478 XXXXXXXX LIVE Common Stock, $0.001 par value 04/02/2025 0001402328 Sunshine Biopharma Inc. 867781700 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 Rule 13d-1(c) BIGGER CAPITAL FUND L P a DE 0.00 297101.00 0.00 297101.00 297101.00 N 8.17 PN Bigger Capital Fund GP, LLC a DE 0.00 297101.00 0.00 297101.00 297101.00 N 8.17 OO Bigger Michael a X1 0.00 297101.00 0.00 297101.00 297101.00 N 8.17 IN Sunshine Biopharma Inc. 333 Las Olas Way, CU4, Suite 433, Fort Lauderdale, FL 33301 Bigger Capital Fund, LP ("Bigger Capital") Bigger Capital Fund GP, LLC ("Bigger GP") Michael Bigger Each of the foregoing is referred to as a "Reporting Person" and collectively as the "Reporting Persons." Bigger Capital Fund, LP 11700 W Charleston Blvd. 170-659 Las Vegas, NV 89135 Bigger Capital Fund GP, LLC 11700 W Charleston Blvd. 170-659 Las Vegas, NV 89135 Michael Bigger 11700 W Charleston Blvd. 170-659 Las Vegas, NV 89135 Bigger Capital Fund, LP Delaware Bigger Capital Fund GP, LLC Delaware Michael Bigger USA Y As of April 2, 2025, Bigger Capital beneficially owned 297,101 shares of Common Stock. Bigger GP, as the general partner of Bigger Capital, may be deemed to beneficially own the Issuer's securities described herein. Mr. Bigger, as the managing member Bigger GP, the general partner of Bigger Capital, may be deemed to beneficially own the Issuer's securities described herein beneficially owned by Bigger Capital. The foregoing should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of any shares of Common Stock owned by another Reporting Person or any other person. Each of Bigger GP and Mr. Bigger disclaims beneficial ownership of the shares of Common Stock beneficially owned by Bigger Capital. The filing of this statement shall not be construed as an admission that any such person or entity is the beneficial owner of any such securities. The following percentages are based on 3,635,945 shares of Common Stock outstanding immediately after the offering based upon the Issuer's Prospectus Supplement filed under Rule 424(b)(5) with the Securities and Exchange Commission on April 3, 2025. As of the close of business on April 2, 2025, each of Bigger Capital and Bigger GP may be deemed to beneficially own approximately 8.17% of the outstanding shares of Common Stock. As of the close of business on April 2, 2025, Mr. Bigger may be deemed to beneficially own approximately 8.17% of the outstanding shares of Common Stock. See Cover Pages Items 5-9. See Cover Pages Items 5-9. See Cover Pages Items 5-9. See Cover Pages Items 5-9. Y N Bigger GP and Mr. Bigger may be deemed to share voting and dispositive power over the shares of Common Stock beneficially owned by Bigger Capital. Y N See Exhibit 99.1. Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. BIGGER CAPITAL FUND L P /s/ Michael Bigger 04/11/2025 Bigger Capital Fund GP, LLC /s/ Michael Bigger 04/11/2025 Bigger Michael /s/ Michael Bigger 04/11/2025